Abbott's Appeal Bid Nixed In Norvir Pricing Suits
A federal judge has shot down Abbott Laboratories' bid for an interlocutory appeal of her decision not to dismiss claims from four suits accusing the pharmaceutical company of illegally jacking up...To view the full article, register now.
Already a subscriber? Click here to view full article